Association between plasma homocysteine levels and mortality in elderly patients with mental illness

Dementia and Geriatric Cognitive Disorders

Volumn 27, Issue 6, 2009, Pages 579-583

  Nilsson, Karin ^a   Gustafson, Lars ^a   Hultberg, Björn ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cobalamin; Creatinine; Cystatin C; Folate; Homocysteine; Mortality; Psychogeriatric patients; Vascular disease

Indexed keywords

COBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; AMINO ACID BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE MARKER; FEMALE; FOLIC ACID BLOOD LEVEL; HOMOCYSTEINE BLOOD LEVEL; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MORTALITY; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; PROGNOSIS; PSYCHOSIS; RISK FACTOR; SURVIVAL TIME; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; KAPLAN-MEIERS ESTIMATE; KIDNEY FUNCTION TESTS; MALE; MENTAL DISORDERS; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; SURVIVAL ANALYSIS; VASCULAR DISEASES; VITAMIN B 12;

EID: 67650099739     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000228260     Document Type: Article

References (25)

1. Nilsson K, Gustafson L, Fäldt R, Andersson A, Brattström L, Lindgren A, Israelsson B, Hultberg B:Hyperhomocysteinemia - a common finding in a psychogeriatric population. Europ J Clin Invest 1996;26:853-859.
2. Joosten E, Lesaffre E, Riezler R, Ghekiere V, Dereymaeker L, Pelemans W, Dejaeger E:Is metabolic evidence for vitamin B-12 and fo-late deficiency more frequent in elderly patients with Alzheimer's disease? J Geront Med Sci 1997;52:M76-M79.
3. 12 and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998;55:1449-1455.
4. McCaddon A, Davies G, Hudson P, Tandy S, Cattel H:Total serum homocysteine in senile dementia of Alzheimer type. Int J Ger Psych 1998;13:235-239.
5. Lehmann M, Gottfries CG, Regland B: Identification of cognitive impairment in the elderly:homocysteine is an early marker. Dementia 1999;10:12-20.
6. Refsum H, Smith DA, Ueland PM, Nexö E, Clarke R, McPartlin J, Johnston C, Engbaek F, Schneede J, McPartlin C, Scott JM:Facts and recommendations about total homocysteine determinations:an expert opinion. Clin Chem 2004;50:3-32.
7. Obeid R, Herrmann W:Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett 20 06;580:2994-3005.
8. Bottiglieri T: Folate, vitamin B-12 and neuropsychiatric disorders. Nutr Rev 1996;54:382-390.
9. Menon V, Sarnak MJ, Greene T, Wang X, Pereira AA, Beck GJ, Kusek JW, Selhub J, Collins AJ, Levey AS, Shlipak MG:Relationship between homocysteine and mortality in chronic kidney disease. Circulation 2006;113:1572-1577.
10. Wald DS, Law M, Morris JK:Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002;325:1202-1209.
11. Homocysteine Studies Collaboration:Ho-mocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002;288:2015-2022.
12. Castro R, Rivera I, Blom HJ, Jakobs C, Tava-res de Almeida I: Homocysteine metabolism, hyperhomocysteinaemia and vascular disease:an overview. J Inher Metab Dis 2006;29:3-20.
13. Nygard O, Refsum H, Ueland PM, Vollset SE: Major lifestyle determinants of plasma total homocysteine distribution:the Hordaland Homocysteine Study. Am J Clin Nutr 1998;67:263-270.
14. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE:Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997;337:230-236.
15. Shishehbor MH, Oliveira LP, Lauer MS, Sprecher DL, Wolski K, Cho L, Hoogwerf BJ, Hazen SL: Emerging cardiovascular risk factors that account for a significant portion of attributable mortality risk in chronic kidney disease. Am J Cardiol 2008;101:1741- 1746.
16. Bostom AG, Silbershatz H, Rosenberg IH, Selhub J, D'Agostino RB, Wolf PA, Jacques PF, Wilson PW:Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Fram-ingham men and women. Arch Intern Med 1999;159:10 49 -10 80.
17. Kark JD, Selhub J, Adler B, Gofin J, Abramson JH, Friedman G, Rosenberg IH:Nonfasting plasma total homocysteine level and mortality in middle-aged and elderly men and women in Jerusalem. Ann Intern Med 1999;131:321-330.
18. Vollset SE, Refsum H, Tverdal A, Nygård O, Nordrehaug JE, Tell GS, Ueland PM:Plasma total homocysteine and cardiovascular and noncardiovascular mortality:the Hordaland Homocysteine Study. Am J Clin Nutr 2001;74 :130 -136.
19. Gonzalez S, Huerta JM, Fernandez S, Patterson AM, Lasheras C:Homocysteine increases the risk of mortality in elderly individuals. Brit J Nutr 2007;97:11 3 8 -114 3 .
20. Dangour AD, Breeze E, Clarke R, Shetty PS, Uauy R, Fletcher AE:Plasma homocysteine, but not folate or vitamin B-12, predicts mortality in older people in the United K ingdom. J Nutr 2008;138:1121-1128.
21. American Psychiatric Association:DSM IV:Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
22. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E: Mild cognitive impairment:clinical characterization and outcome. Arch Neurol 1999;56:303-308.
23. Andersson A, Isaksson A, Brattström L, Hultberg B:Homocysteine and other thiols determined in plasma by HPLC and thiol-specific post-column derivatization. Clin Chem 1993;39:1590 -1597.
24. Nilsson K, Gustafson L, Hultberg B:Plasma homocysteine, cobalamin/folate status, and vascular disease in a large population of psychogeriatric patients. Dem Geriatr Cogn Disord 2006;22:358-366.
25. Refsum H, Nurk E, Smith D, Ueland PM, Gjesdal CG, Bjelland I, Tverdal A, Tell GS, Nygard O, Vollset SE:The Hordaland Homocysteine Study:a community-based study of homocysteine, its determinants, and association with disease. J Nutr 2006;136:1731S-1740S.